Moving to a lower carbon preventer inhaler- patient leaflet
Fostair® and Bibecfo® have extra-fine particles and are more potent than traditional beclometasone inhalers
If an MDI is required, Bibecfo is the first line MDI beclomethasone + formoterol inhaler and Fostair is 2nd line
| Pack |
|---|
| 120 dose |
| Pack |
|---|
| 120 dose |
| Pack |
|---|
| 120 dose |
| Pack |
|---|
| 120 dose |
| Pack |
|---|
| 120 dose |
| Pack |
|---|
| 120 dose |
First line choice - Fobumix Easyhaler
Second line choice - Symbicort Turbohaler
First Line
| Pack |
|---|
| 120 dose |
First Line
| Pack |
|---|
| 60 dose |
| 120 dose |
First Line
| Pack |
|---|
| 60 dose |
Second Line
| Pack |
|---|
| 120 dose |
Second Line
| Pack |
|---|
| 120 dose |
Second Line
| Pack |
|---|
| 60 dose |
For paediatric patients aged 5 - 11
| Pack |
|---|
| 120 dose |
Seretide: Third line. Paediatrics use only.
Third line. Paediatrics use only.
| Pack |
|---|
| 120 dose |
Third line. Paediatrics use only.
| Pack |
|---|
| 120 dose |
Third line. Paediatrics use only.
| Pack |
|---|
| 60 dose |
Inhalation (delivered dose) of fluticasone fuorate 92micrograms once daily is approximately equivalent to fluticasone propionate 250micrograms twice daily.
Lower strength 92/22 device for use in Asthma and COPD. The higher strength 184/22 for use in Asthma
only.
| Pack |
|---|
| 30 dose |
| Pack |
|---|
| 30 dose |